Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Teijin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teijin's 2013 immunology sales performance.

Pfizer/Opko's long-acting growth hormone misses mark in trial

Pfizer/Opko's long-acting growth hormone misses mark in trial

Also in the running is Versartis, whose somavaratan (VRS-317) is in late-stage trials and was recently licensed to Teijin in Japan.

Deal Watch August 2016

Deal Watch August 2016 252. Versartis. Teijin (JP). Licence Japan. Somavaratan, long-acting form of rhGH, for paediatric and adult growth hormone deficiency in phase II/III in Japan.

Teijin and Chugai to co-develop Ipsen's diabetes drug in Japan

Teijin had been developing ITM-077 alone and now expects to speed up the development and gain early regulatory approval with Chugai's help. ... Teijin and Chugai are now working together to establish a co-development plan.

1

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...
Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...